These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18207305

  • 1. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
    Royer PJ, Bougras G, Ebstein F, Leveque L, Tanguy-Royer S, Simon T, Juge-Morineau N, Chevallier P, Harousseau JL, Gregoire M.
    Exp Hematol; 2008 Mar; 36(3):329-39. PubMed ID: 18207305
    [Abstract] [Full Text] [Related]

  • 2. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M.
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
    Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, Park KS, Lee IK, Chung IJ, Hwang TJ, Kim HJ.
    J Clin Apher; 2004 May; 19(2):66-70. PubMed ID: 15274198
    [Abstract] [Full Text] [Related]

  • 4. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A, Van de Velde AL, Nijs G, Braeckman T, Stein B, De Vries JM, Berneman ZN, Van Tendeloo VF.
    Cytotherapy; 2009 May; 11(5):653-68. PubMed ID: 19530029
    [Abstract] [Full Text] [Related]

  • 5. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C, Liepert A, Dreyig J, Kremser A, Kroell T, Freudenreich M, Schmid C, Schweiger C, Tischer J, Kolb HJ, Schmetzer H.
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M.
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [Abstract] [Full Text] [Related]

  • 7. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S, Zitzelsberger H, Kroell T, Pelka-Fleischer R, Salem A, de Valle F, Schweiger C, Nuessler V, Schmid C, Kolb HJ, Schmetzer HM.
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [Abstract] [Full Text] [Related]

  • 8. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].
    Ge W, You SG, Wang YF, Li CH, Liu XF, He XP, Ma S, Qiu L.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):461-4. PubMed ID: 16383235
    [Abstract] [Full Text] [Related]

  • 9. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M.
    Cancer Res; 2002 May 15; 62(10):2861-8. PubMed ID: 12019165
    [Abstract] [Full Text] [Related]

  • 10. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
    Draube A, Beyer M, Wolf J.
    Eur J Haematol; 2008 Oct 15; 81(4):281-8. PubMed ID: 18573171
    [Abstract] [Full Text] [Related]

  • 11. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.
    Schmitt A, Reinhardt P, Hus I, Tabarkiewicz J, Roliñski J, Barth T, Giannopoulos K, Dmoszyñska A, Wiesneth M, Schmitt M.
    Transfusion; 2007 Sep 15; 47(9):1588-94. PubMed ID: 17725721
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J, Rolinski J, Hus I, Dmoszynska A, Wiesneth M, Schmitt M.
    Int J Oncol; 2006 Apr 15; 28(4):855-61. PubMed ID: 16525634
    [Abstract] [Full Text] [Related]

  • 13. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK, Lane TA, Ball ED.
    Exp Hematol; 2008 Apr 15; 36(4):486-94. PubMed ID: 18249062
    [Abstract] [Full Text] [Related]

  • 14. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
    Bontkes HJ, Ruizendaal JJ, Kramer D, Santegoets SJ, Scheper RJ, de Gruijl TD, Meijer CJ, Hooijberg E.
    J Immunother; 2006 Apr 15; 29(2):188-200. PubMed ID: 16531819
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
    Kremser A, Dressig J, Grabrucker C, Liepert A, Kroell T, Scholl N, Schmid C, Tischer J, Kufner S, Salih H, Kolb HJ, Schmetzer H.
    J Immunother; 2010 Apr 15; 33(2):185-99. PubMed ID: 20139775
    [Abstract] [Full Text] [Related]

  • 16. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH, Kang HK, Park JS, Kim SK, Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ.
    J Clin Apher; 2006 Dec 15; 21(4):233-40. PubMed ID: 17120232
    [Abstract] [Full Text] [Related]

  • 17. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
    Tan YF, Sim GC, Habsah A, Leong CF, Cheong SK.
    Malays J Pathol; 2008 Dec 15; 30(2):73-9. PubMed ID: 19291915
    [Abstract] [Full Text] [Related]

  • 18. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R, Pedersen AE, Met O, Hansen MH, Berntsen A, Svane IM.
    Vaccine; 2008 Jun 02; 26(23):2824-32. PubMed ID: 18450338
    [Abstract] [Full Text] [Related]

  • 19. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
    Antonia SJ, Mirza N, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Lee JH, Menander K, Chada S, Gabrilovich DI.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):878-87. PubMed ID: 16467102
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
    van de Loosdrecht AA, van den Ancker W, Houtenbos I, Ossenkoppele GJ, Westers TM.
    Handb Exp Pharmacol; 2009 Feb 01; (188):319-48. PubMed ID: 19031033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.